Delgocitinib bulk supplier for pharma manufacturers

Delgocitinib 2% Suppliers & Bulk Manufacturers

Available Forms: Creams

Available Strengths: 2%

Reference Brands: Anzupgo (USA/EU)

Delgocitinib is a topical Janus kinase (JAK) inhibitor used to treat moderate-to-severe chronic hand eczema in adults. It works by blocking the JAK-STAT signaling pathway, which reduces inflammation and skin lesions. Applied as a 2% cream to affected areas, it helps control eczema symptoms when topical corticosteroids are insufficient or unsuitable. It is not a systemic drug or narcotic and is used only on the skin.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Delgocitinib — third party manufacturing & bulk supply

Delgocitinib 2% is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Delgocitinib is supplied as Creams — a dosage form priced by order value, so the indicative MOQ is a minimum order value of USD 5,000 per product. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Delgocitinib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Delgocitinib →

Back to Listing

Frequently Asked Questions

Delgocitinib is listed as Creams in 2%. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Delgocitinib is referenced against Anzupgo (USA/EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.